Summary
Granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GMCSF), and interleukin-3 (IL-3) stimulate the proliferation, differentiation, and activation of multiple hematopoietic cells. G-CSF acts primarily on mature neutrophils and their precursors, and the ability of this cytokine to promote granulopoiesis in vivo underlies its clinical application in the setting of neutropenia. GM-CSF influences a broader range of cells, including neutrophils, eosinophils, macrophages, erythroid progenitors, megakaryocyte progenitors, and dendritic cells. These properties result in marked immunostimulation, and have led to clinical testing of the cytokine as a vaccine adjuvant. IL-3 augments the numbers and functions of hematopoietic progenitors, mast cells, basophils, neutrophils, macrophages, eosinophils, erythrocytes, megakaryocytes, and dendritic cells.
In this chapter we review the generation and characterization of mice deficient in each of these cytokines. These studies have delineated essential roles for the molecules in hematopoiesis, immunity, and pulmonary homeostasis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Metcalf, D. (1993) Hematopoietic regulators: redundancy or subtlety? Blood 82, 3515–3523.
Demetri, G. D. and Griffin, J. D. (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791–808.
Moore, M. A., Welte, K., Gabrilove, J., and Souza, L. M. (1987) Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis. In: Neth, R., et al., eds. Haematology and Blood Transfusion. Springer-Verlag, Berlin.
Tamura, M., Hattori, K., Namura, H., et al. (1987) Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochem. Biophys. Res. Commun. 142, 454–660.
Pojda, Z., Molineux, G., and Dexter, T. M. (1990) Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp. Hematol. 18, 27–31.
Chang, J. M., Metcalf, D., Gonda, T. J., and Johnson, G. R. (1989) Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J. Clin. Invest. 84, 1488–1496.
Watari, K., Asano, S., Shirafuji, N., et al. (1989) Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73, 117–122.
Mempel, K., Pietsch, T., Menzel, T., Seidler, C., and Welte, K. (1991) Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 77, 1919–1922.
Gasson, J. C., Weisbart, R. H., Kaufman, S. E., et al. (1984) Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 226, 1339–1342.
Cannistra, S. A. and Griffin, J. D. (1988) Regulation of the production and function of granulocytes and monocytes. Semin. Hematol. 25, 173–188.
Caux, C., Massacrier, C., Vanbervliet, B., et al. (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMCSF+TNF alpha. J. Exp. Med. 184, 695–706.
Lopez, A. F., Williamson, D. J., Gamble, J. R., et al. (1986) Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78, 1220–1228.
Ferrero, D., Tarella, C., Badoni, R., et al. (1989) Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitors. Blood 73, 402–405.
Lang, R. A., Metcalf, D., Cuthbertson, R. A., et al. (1987) Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51, 675–686.
Johnson, G. R., Gonda, T. J., Metcalf, D., Hariharan, I. K., and Cory, S. (1989) A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J. 8, 441–448.
Dranoff, G., Jaffee, E., Lazenby, A., et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539–3543.
Rennick, D. M., Lee, F. D., Yokota, T., Arai, K. I., Cantor, H., and Nobel, G. J. (1985) A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: multiple activities of interleukin 3. J. Immunol. 134, 910–914.
Suda, T., Suda, T., Ogawa, M., and Ihle, J. N. (1985) Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture. J. Cell. Physiol. 124, 182–190.
Caux, C., Vanberbliet, B., Massacrier, C., Durand, I., and Banchereau, J. (1996) Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood 87, 2376–2385.
Metcalf, D., Beley, C. G., Johnson, G. R., Nicola, N. A., Lopez, A. F., and Williamson, D. J.. (1986) Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood 68, 46–57.
Kindler, V., Thorens, B., de Kossodo, S., et al. (1986) Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc. Natl. Acad. Sci. USA 83, 1001–1005.
Donahue, R. E., Seehra, J., Metzger, M., et al. (1988) Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 241, 1820–1823.
Gianella-Borradori, A. (1994) Present and future clinical relevance of interleukin 3. Stem Cells 12 (Suppl. 1), 241–248.
Rothenberg, M. E., Owen, W. F. Jr., Silberstein, D. S., et al. (1988) Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81, 1986–1992.
Kimoto, M., Kinder, V., Higaki, M., Ody, C., Izui, S., and Vassalli, P. (1988) Recombinant murine IL-3 fails to stimulate T or B lymphopoiesis in vivo, but enhances immune responses to T cell-dependent antigens. J. Immunol. 140, 1889–1894.
Cannistra, S. A., Vellenga, E., Groshek, P., Rambaldi, A., and Griffin, J. D. (1988) Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 71, 672–676.
Madden, K. B., Urban, J. F. Jr., Ziltener, H. J., Shcrader, J. W., Finkelman, F. D., and Katona, I. M. (1991) Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147, 1387–1391.
Pulaski, B. A., Yeh, K. Y., Shastri, N., et al. (1996) Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex “re-presentation” of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc. Natl. Acad. Sci. USA 93, 3669–3674.
Buchberg, A. M., Bedigian, H. G., Taylor, B. A., et al. (1988) Localization of Evi-2 to chromosome 11: linkage to other protooncogene and growth factor loci using interspecific backcross mice. Oncogene Res. 2, 149–165.
Buchberg, A. M., Brownell, E., Nagata, S. Jenkins, N. A., and Copeland, N. G. (1989) A comprehensive genetic map of murine chromosome 11 reveals extensive linkage conservation between mouse and human. Genetics 122, 153–161.
Barlow, D. P., Bucan, M., Lehrach, H., Hogan, B. L, and Gough, N. M. (1987) Close genetic and physical linkage between the murine haemopoietic growth factor genes GM-CSF and Multi-CSF (IL3). EMBO J. 6, 617–623.
Lieschke, G. J., Grail, D., Hodgson, G., et al. (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737–1746.
Metcalf, D., Lindeman, G. J., and Nicola, N. A. (1995) Analysis of hematopoiesis in max 41 transgenic mice that exhibit sustained elevations of blood granulocytes and monocytes. Blood 85, 2364–2370.
Lieschke, G. J. and Dunn, A. R. (1992) Physiologic role of granulocyte colony stimulating factor: insights from in vivo studies. In: Abraham, N. G., et al., ed. Molecular Biology of Haematopoiesis. Andover, Hants, UK, p. 201.
Layton, J. E., Hockman, H., Sheridan, W. P., and Morstyn, G. (1989) Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 74, 1303–1307.
Basu, S., Hodgson, G., Katz, M., and Dunn, A. R. (2002) Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood 100, 854–861.
Stanley, E., Metcalf, D., Sobieszczuk, P., Gough, N. M., and Dunn, A. R. (1985) The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: evidence for utilisation of alternative promoters. EMBO J. 4, 2569–2573.
Miyatake, S., Otsuka, T., Yokota, T., Lee, F., and Arai, K. (1985) Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J. 4, 2561–2568.
Dranoff, G., Crawford, A. D., Sadelain, M., et al. (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264, 713–716.
Stanley, E., Lieschke, G. J., Grail, D., et al. (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91, 5592–5596.
Robertson, S. A., Roberts, C. T., Farr, K. L., Dunn, A. R., and Seamark, R. F. (1999) Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice. Biol. Reprod. 60, 251–261.
Dranoff, G. and Mulligan, R. C. (1994) Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells 12(Suppl. 1), 173–182; discussion 182–184.
Vremec, D., Lieschke, G. J., Dunn, A. R., Robb, L., Metcalf, D., and Shortman, K. (1997) The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27, 40–44.
Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R., and Cheers, C. (1998) Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91, 863–869.
Wright, J. R. and Clements, J. A. (1987) Metabolism and turnover of lung surfactant. Am. Rev. Respir. Dis. 136, 426–444.
Wright, J. R. and Dobbs, L. G. (1991) Regulation of pulmonary surfactant secretion and clearance. Annu. Rev. Physiol. 53, 395–414.
Ikegami, M., Hull, W. M., Yoshida, M., Wert, S. E., and Whitsett, J. A. (2001) SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L697 - L703.
Rosen, S. H., Castleman, B., and Liebow, A. A. (1958) Pulmonary alveolar proteinosis. N. Engl. J. Med. 258, 1123–1142.
Yoshida, M., Ikegami, M., Reed, J. A., Chroneos, Z. C., and Whitsett, J. A. (2001) GM-CSF regulates protein and lipid catabolism by alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L379 - L386.
Ikegami, M., Veda, T., Hull, W., et al. (1996) Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am. J. Physiol. 270, L650 - L658.
Huffman, J. A., Hull, W. M., Dranoff, G., Mulligan, R. C., and Whitsett, J. A. (1996) Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97, 649–655.
Zsengeller, Z. K., Reed, J. A., Bachurski, C. J. et al. (1998) Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice. Hum. Gene Ther. 9, 2101–2109.
Reed, J. A., Ikegami, M., Cianciolo, E. R., et al. (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am. J. Physiol. 276 (4 Pt 1), L556 - L563.
Kitamura, T., Tanaka, N., Watanabe, J., et al. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190, 875–880.
Dirksen, U., Nishinakamura, R., Groneck, P., et al. (1997) Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 100, 2211–2217.
Tchou-Wong, K. M., Harkin, T. J., Chi, C., Bodkin, M., and Rom, W. N. (1997) GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 156, 1999–2002.
Thomassen, M. J., Yi, T., Raychaudhuri, B., Malur, A., and Kavuru, M. S. (2000) Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin. Immunol. 95, 85–92.
Barraclough, R. M. and Gillies, A. J. (2001) Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 56, 664–665.
Kavuru, M. S., Sullivan, E. J., Piccin, R., Thomassen, M. J., and Stoller, J. K. (2000) Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 161, 1143–1148.
Seymour, J. F., Dunn, A. R., Vincetn, J. M., Presneill, J. J., and Pain, M. C. (1996) Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N. Engl. J. Med. 335, 1924–1925.
Paine, R. 3rd, Preston, A. M., Wilcoxen, S., et al. (2000) Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 164, 2602–2609.
LeVine, A. M., Reed, J. A., Kurak, K. E., Cianciolo, E., and Whitsett, J. A. (1999) GM-CSFdeficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103, 563–569.
Paine, R. 3rd, Morris, S. B., Jin, H., et al. (2001) Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1210 - L1218.
Shibata, Y., Berclaz, P. Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., and Trapnell, B. C. (2001) GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15, 557–567.
Zhan, Y., Basu, S., Lieschke, G. J., Grail, D., Dunn, A. R., and Cheers, C. (1999) Functional deficiencies of peritoneal cells from gene-targeted mice lacking G-CSF or GM-CSF. J. Leukoc. Biol. 65, 256–264.
Bilyk, N. and Holt, P. G. (1993) Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 177, 1773–1777.
Wada, H., Noguchi, Y., Marino, M. W., Dnn, A. R., and Old, L. J. (1997) T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 94, 12557–12561.
Noguchi, Y., Wada, H., Marino, M. W., and Old, L. J. (1998) Regulation of IFN-gamma production in granulocyte-macrophage colony-stimulating factor-deficient mice. Eur. J. Immunol. 28, 3980–3988.
Campbell, I. K., Rich, M. J., Bischof, R. J., Dunn, A. R., Grail, D., and Hamilton, J. A. (1998) Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161, 3639–3644.
McQualter, J. L., Darwiche, R., Ewing, C., et al. (2001) Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873–882.
Basu, S., Dunn, A. R., Marino, M. W., et al. (1997) Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 159, 1412–1417.
Mach, N., Lantz, C. S., Galli, S. J., et al. (1998) Involvement of interleukin-3 in delayed-type hypersensitivity. Blood 91, 778–783.
Galli, S. J., Zsebo, K. M., and Geissler, E. N. (1994) The kit ligand, stem cell factor. Adv. Immunol. 55, 1–96.
Lantz, C. S., Boesiger, J., Song, C. H., et al. (1998) Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90–93.
Eisen, H. N., Orris, L., and Belman, S. (1952) Elicitation of delayed allergic skin reactions with hap-tens: the dependence of elicitation on hapten combination with protein. J. Exp. Med. 95, 473–475.
Silberberg, I., Baer, R. L., and Rosenthal, S. A. (1976) The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. J. Invest. Dermatol. 66, 210–217.
Gocinski, B. L. and Tigelaar, R. E. (1990) Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144, 4121–4128.
Kitamura, T., Onishi, M., Kinoshita, S., Shibuya, A., Miyajima, A., and Nolan G. P. (1991) Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66, 1165–1174.
Tavernier, J., Devos, R., Cornelis, S., et al. (1991) A human high affinity interleukin-5 receptor (ILSR) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66, 1175–1184.
Itoh, N., Yonehara, S., Schreurs, J., et al. (1990) Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family. Science 247, 324–327.
Gorman, D. M., Itoh, N., Kitamura, T., et al. (1990) Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family. Proc. Natl. Acad. Sci. USA 87, 5459–5463.
Nishinakamura, R., Nakayama, N., Hirabayashi, Y., et al. (1995) Mice deficient for the IL-3/GMCSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 2, 211–222.
Robb, L., Drinkwater, C. C., Metcalf, D., et al. (1995) Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA 92, 9565–9569.
Kopf, M., Brombacher, F., Hodgkin, P. D., et al. (1996) IL-S-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15–24.
Reed, J. A., Ikegami, M., Robb, L., Begley, C. G., Ross, G., and Whitsett, J. A. (2000) Distinct changes in pulmonary surfactant homeostasis in common beta-chain- and GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L1164 - L1171.
Nishinakamura, R., Wiler, R., Dirksen, U., et al. (1996) The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J. Exp. Med. 183, 2657–2662.
Scott, C. L., Hughes, D. A., Cary, D., Nicola, N. A., Begley, C. G., and Robb, L. (1998) Functional analysis of mature hematopoietic cells from mice lacking the betac chain of the granulocyte-macrophage colony-stimulating factor receptor. Blood 92, 4119–4127.
Yamaguchi, Y., Hayashi, Y., Sughama, Y., et al. (1988) Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167, 1737–1742.
Nicola, N. A., Robb, L., Metcalf, D., Cary, D., Drinkwater, C. G., and Begley, C. G. (1996) Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor beta-chain: implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells. Blood 87, 2665–2674.
Seymour, J. F., Lieschke, G. J., Grail, D., Quilici, C., Hodgson, G., and Dunn, A. R. (1997) Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90, 3037–3049.
Gillessen, S., Mach, N., Small, C., Mihm, M., and Dranoff, G. (2001) Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 97, 922–9928.
Lee, J. S. and Young, I. G. (1989) Fine-structure mapping of the murine IL-3 and GM-CSF genes by pulsed-field gel electrophoresis and molecular cloning. Genomics 5, 359–362.
Lieschke, G. J., Stanley, E., Grail, D., et al. (1994) Mice lacking both macrophage-and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 84, 27–35.
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W. Jr., et al. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 87, 4828–4832.
Yoshida, H., Hayashi, S., Kunisada, T., et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442–444.
Marks, S. C. Jr. and Lane, P. W. (1976) Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67, 11–18.
Wiktor-Jedrzejczak, W. W., Ahmed, A., Szczylik, C., and Skelly, R. R. (1982) Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156, 1516–1527.
Begg, S. K., Radley, J. M., Pllard, J. W., Chisholm, O. T., Stanley, E. R., and Bertoncello, I. (1993) Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177, 237–242.
Begg, S. K. and Bertoncello, I. (1993) The hematopoietic deficiencies in osteopetrotic (op/op) mice are not permanent, but progressively correct with age. Exp. Hematol. 21, 493–495.
Nilsson, S. K. and Bertoncello, I. (1994) Age-related changes in extramedullary hematopoiesis in the spleen of normal and perturbed osteopetrotic (op/op) mice. Exp. Hematol. 22, 377–383.
Wu, H., Liu, X., Jaenisch, R., and Lodish, H. F. (1995) Generation of committed erythroid BFUE and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59–67.
Lin, C. S., Lim, S. K., D’Agati, V., and Constantini, F. (1996) Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10, 154–164.
Wu, H., Lee, S. H., Gao, J., Liu, X., and Iruela-Arispe, M. L. (1999) Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126, 3597–3605.
Jegalian, A. G., Acurio, A., Dranoff, G., and Wu, H. (2002) Erythropoietin receptor haploinsufficiency and in vivo interplay with granulocyte-macrophage colony-stimulating factor and interleukin 3. Blood 99, 2603–2605.
Nishinakamura, R., Miyajima, A., Mee, P. J., Tybulewicz, V. L., and Murray, R. (1996) Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin3/interleukin-5 functions. Blood 88, 2458–2464.
Gurney, A. L., Carver-Moore, K., de Sauvage, F. J., and Moore, M. W. (1994) Thrombocytopenia in c-mpl-deficient mice. Science 265, 1445–1447.
Alexander, W. S., Roberts, A. W., Nicola, N. A., Li, R., and Metcalf, D. (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87, 2162–2170.
de Sauvage, F. J., Carver-Moore, K., Luoh, S. M., et al. (1996) Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med. 183, 651–656.
Gainsford, T., Roberts, A. W., Kimura, S., et al. (1998) Cytokine production and function in cmpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Blood 91, 2745–2752.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Enzler, T., Dranoff, G. (2003). G-CSF, GM-CSF, and IL-3 Knockout Mice. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-405-4_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-415-9
Online ISBN: 978-1-59259-405-4
eBook Packages: Springer Book Archive